Companies / Treace

Treace coverage

13 issues

• AOFAS Savannah Preview: MIS Achilles and the New Launches

  Unsolicited advice for exhibitors and surgeons, plus a challenger to Arthrex PARS.

• Treace and Paragon 28 by the Numbers, Plus Lapidus Launches

  FY2023 results for the two public pure-plays, and a newcomer in biologics.

• Year-End Launches: DJO Nitinol, a Treace Plate, and Stryker Anchors

  Q4 is usually about hitting numbers. This one brought real products instead.

• The Treace Report: Inside Culper Research's Short Thesis

  An activist short seller accuses Treace of fraudulent coding. We read all 21 pages.

• AOFAS Preview: Ossio, Fusion Orthopedics, and Conventus Flower

  Disruptive up-and-comers heading to Quebec City, and the symposiums worth attending.

• A New 3D PSI Player Enters the Rotational Lapidus Race

  A new product, an AR acquisition, and patient-specific instrumentation for Lapidus.

• ConMed Acquires In2Bones — Who's Next to Go?

  The details of the deal, plus Q1 earnings from Treace and Paragon 28.

• Fusion Orthopedics Challenges Treace in the Lapidus Fight

  A rotational Lapidus jig, a radiolucent frame, and a wireless scope walk into a quarter.

• CrossRoads Sells to DePuy Synthes, Plus the Bunion DTC Marketing War

  J&J finally makes its move, and a look at who is winning direct-to-patient.

• Golden Demobone Awards: Treace Takes Rotational Bunion, Plus a Market Share Read

  A winner in the year's most contested category, plus where market share is heading.

• Golden Demobone Awards: Rotational Bunion and MIS Products of the Year

  The two hottest markets in foot and ankle go head to head for hardware of the year.

• Elective Surgery Returns, and the 2020 Extremity Acquisition Scorecard

  Conventus takes Flower, Anika takes two, and the obvious question of who's next.

• Michael Jordan's Navicular and the Future of Med Ed

  Stress fractures, The Last Dance, and where medical education goes after COVID.